Left atrial appendage closure versus medical therapy for atrial fibrillation: the APPLY study
June 23, 2020 | 10.4244/EIJ-D-20-00201
Showing 1-20 of 32 articles
Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure
June 12, 2020 | 10.4244/EIJ-D-19-00442
Contained annulus ruptures – the price to pay for optimal haemodynamic results?
May 20, 2020 | 10.4244/EIJV16I1A3
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
January 17, 2020 | 10.4244/EIJY19M08_01
Amplatzer left atrial appendage closure: access via transseptal puncture versus patent foramen ovale or atrial septal defect
August 27, 2019 | 10.4244/EIJ-D-19-00442
Interventions for valvular disease
The Allegra transcatheter heart valve: European multicentre experience with a novel self-expanding transcatheter aortic valve May 20, 2019 | 10.4244/EIJ-D-18-00861
Interventions for valvular disease
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies March 20, 2018 | 10.4244/EIJ-D-17-00704
Interventions for stroke
Left atrial appendage occlusion September 24, 2017 | 10.4244/EIJ-D-17-00412
Interventions for stroke
Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale September 20, 2017 | 10.4244/EIJ-D-17-00061
Interventions for valvular disease
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis April 7, 2017 | 10.4244/EIJ-D-16-00677
Interventions for valvular disease
Feasibility of concomitant MitraClip and left atrial appendage occlusion March 20, 2017 | 10.4244/EIJ-D-16-00784
Interventions for valvular disease
Clipping of the tricuspid valve: proposal of a “Rosetta Stone” nomenclature for procedural 3D transoesophageal guidance February 3, 2017 | 10.4244/EIJ-D-16-00307
Coronary interventions
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction December 9, 2016 | 10.4244/EIJY15M12_09
Interventions for valvular disease
Transcatheter direct mitral annuloplasty with Cardioband: feasibility and efficacy trial in an acute preclinical model December 9, 2016 | 10.4244/EIJY15M11_06
Interventions for valvular disease
Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model September 18, 2016 | 10.4244/EIJV12I7A150
Interventions for valvular disease
The Cardioband: strategies for optimal patient selection and optimised results September 18, 2016 | 10.4244/EIJV12SYA15
Interventions for valvular disease
Percutaneous mitral valve repair and replacement: complementary or competitive techniques? September 18, 2016 | 10.4244/EIJV12SYA26
Interventions for valvular disease
Transfemoral tricuspid valve-in-valve implantation: snare it to make it simpler! June 20, 2016 | 10.4244/EIJY15M09_13
Interventions for stroke
Patent foramen ovale: indications for closure and techniques May 16, 2016 | 10.4244/EIJV12SXA2
Interventions for valvular disease
Catheter-based treatment of paravalvular leaks May 16, 2016 | 10.4244/EIJV12SXA11